TFF Pharmaceuticals Inc
NASDAQ:TFFP
Income Statement
Earnings Waterfall
TFF Pharmaceuticals Inc
Income Statement
TFF Pharmaceuticals Inc
| Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+250%
|
0
+29%
|
0
+44%
|
0
+23%
|
0
+25%
|
1
+150%
|
0
-4%
|
1
+63%
|
1
+19%
|
1
-21%
|
1
+20%
|
1
+36%
|
1
-3%
|
|
| Operating Income | |||||||||||||||||||||||||
| Operating Expenses |
(4)
|
(6)
|
(6)
|
(8)
|
(12)
|
(14)
|
(15)
|
(17)
|
(19)
|
(23)
|
(24)
|
(28)
|
(32)
|
(32)
|
(36)
|
(35)
|
(32)
|
(31)
|
(28)
|
(25)
|
(23)
|
(21)
|
(21)
|
(20)
|
|
| Selling, General & Administrative |
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(5)
|
(7)
|
(8)
|
(9)
|
(10)
|
(10)
|
(11)
|
(11)
|
(12)
|
(13)
|
(14)
|
(14)
|
(13)
|
(12)
|
(11)
|
(10)
|
(9)
|
(9)
|
|
| Research & Development |
(1)
|
(3)
|
(3)
|
(6)
|
(9)
|
(9)
|
(11)
|
(11)
|
(11)
|
(14)
|
(14)
|
(17)
|
(21)
|
(21)
|
(24)
|
(21)
|
(19)
|
(17)
|
(15)
|
(13)
|
(12)
|
(12)
|
(12)
|
(11)
|
|
| Operating Income |
(4)
N/A
|
(6)
-50%
|
(6)
-1%
|
(8)
-38%
|
(12)
-47%
|
(14)
-14%
|
(15)
-12%
|
(17)
-15%
|
(19)
-7%
|
(23)
-22%
|
(24)
-6%
|
(28)
-15%
|
(32)
-15%
|
(32)
-2%
|
(36)
-11%
|
(35)
+4%
|
(32)
+8%
|
(31)
+4%
|
(27)
+12%
|
(24)
+11%
|
(22)
+8%
|
(21)
+6%
|
(20)
+5%
|
(19)
+4%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(4)
N/A
|
(6)
-50%
|
(6)
-1%
|
(8)
-39%
|
(12)
-47%
|
(13)
-14%
|
(15)
-12%
|
(17)
-15%
|
(19)
-7%
|
(22)
-21%
|
(23)
-4%
|
(27)
-16%
|
(31)
-15%
|
(32)
-2%
|
(36)
-13%
|
(34)
+4%
|
(32)
+8%
|
(30)
+4%
|
(27)
+12%
|
(24)
+11%
|
(21)
+11%
|
(20)
+6%
|
(19)
+3%
|
(19)
+4%
|
|
| Net Income | |||||||||||||||||||||||||
| Income from Continuing Operations |
(4)
|
(6)
|
(6)
|
(8)
|
(12)
|
(13)
|
(15)
|
(17)
|
(19)
|
(22)
|
(23)
|
(27)
|
(31)
|
(32)
|
(36)
|
(34)
|
(32)
|
(30)
|
(27)
|
(24)
|
(21)
|
(20)
|
(19)
|
(19)
|
|
| Net Income (Common) |
(5)
N/A
|
(7)
-47%
|
(7)
-1%
|
(9)
-34%
|
(37)
-304%
|
(38)
-4%
|
(39)
-4%
|
(41)
-5%
|
(19)
+55%
|
(22)
-21%
|
(23)
-4%
|
(27)
-16%
|
(31)
-15%
|
(32)
-2%
|
(36)
-13%
|
(34)
+4%
|
(32)
+8%
|
(30)
+4%
|
(27)
+12%
|
(24)
+11%
|
(21)
+11%
|
(20)
+6%
|
(19)
+3%
|
(19)
+4%
|
|
| EPS (Diluted) |
-0.26
N/A
|
-0.37
-42%
|
-0.38
-3%
|
-0.5
-32%
|
-1.99
-298%
|
-2
-1%
|
-2.06
-3%
|
-1.98
+4%
|
-0.91
+54%
|
-0.96
-5%
|
-0.91
+5%
|
-1.05
-15%
|
-1.25
-19%
|
-1.25
N/A
|
-1.41
-13%
|
-1.36
+4%
|
-1.06
+22%
|
-0.84
+21%
|
-0.73
+13%
|
-12.56
-1 621%
|
-11.85
+6%
|
-8.34
+30%
|
-5.28
+37%
|
-4.23
+20%
|
|